Caris Life Sciences
Tracked across 1 events · 31 articles · First seen May 29, 2026 · Last active Jun 16, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Caris Life Sciences is facing investigations by multiple law firms for alleged securities fraud due to lower-than-expected Q1 revenues and delayed FDA clearance for its TriNav Advance product, which caused a significant drop in its stock price.
Jun 02, 2026 · 31 articles
100
The Schall Law Firm announced investigation Caris Life SciencesTriSalus Securities Fraud...
100
Pomerantz LLP investigating claims Caris Life SciencesTriSalus Securities Fraud...
92
Caris Life Sciences reported Q1 resultsTriSalus Securities Fraud...
85
Caris Life Sciences delayed FDA clearance United States — Food and Drug AdministrationTriSalus Securities Fraud...
ERGEN INTELLIGENCE
Track Caris Life Sciences live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard